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Abstract
Background: The renal function plays a leading role in long-term control of arterial pressure. The comparative
analysis of renal cortex transcriptome in ISIAH rats with inherited stress-induced arterial hypertension and
normotensive WAG rats was performed using RNA-Seq approach. The goal of the study was to identify the
differentially expressed genes (DEGs) related to hypertension and to detect the pathways contributing to the
differences in renal functions in ISIAH and WAG rats.
Results: The analysis revealed 716 genes differentially expressed in renal cortex of ISIAH and WAG rats, 42 of them
were associated with arterial hypertension and regulation of blood pressure (BP). Several Gene Ontology (GO) terms
significantly enriched with DEGs suggested the existence of the hormone dependent interstrain differences in
renal cortex function. Multiple DEGs were associated with regulation of blood pressure and blood circulation,
with the response to stress (including oxidative stress, hypoxia, and fluid shear stress) and its regulation. Several other
processes which may contribute to hypertension development in ISIAH rats were: ion transport, regulation of calcium
ion transport, homeostatic process, tissue remodeling, immune system process and regulation of immune response.
KEGG analysis marked out several pathways significantly enriched with DEGs related to immune system function,
to steroid hormone biosynthesis, tryptophan, glutathione, nitrogen, and drug metabolism.
Conclusions: The results of the study provide a basis for identification of potential biomarkers of stress-sensitive
hypertension and for further investigation of the mechanisms that affect renal cortex function and hypertension
development.
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Background
The etiology of essential hypertension is multifactorial.
Many researchers agree that the renal function plays a
leading role in long-term control of arterial pressure. It is
thought that hypertension may be a consequence of abnor-
mal water-electrolyte balancing by kidney [1, 2]. However,
the number of factors involved in the pathogenesis of
hypertension is constantly increasing [3], and the molecular
mechanisms of essential hypertension development still
remain uncertain.
The use of experimental animal models provides valuable
information to elucidate the nature of polygenic traits [4].
One of these is the ISIAH (Inherited Stress-Induced
Arterial Hypertension) rat strain which was developed to
study the mechanisms of the stress-sensitive hypertension
and its complications. The ISIAH rats were selected from
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an outbred Wistar rat population for a systolic arterial
blood pressure (SABP) increase induced by 30 min restraint
stress in a small cylindrical wire mesh cage. More than 30
generations of close inbreeding by brother-sister mating
resulted in a high genetic homogeneity of the ISIAH strain
[5]. Starting from the age of 6 weeks, the ISIAH rats have
elevated SABP at basal condition (175.0 ± 3.5 mmHg in
males and 165.0 ± 3.0 mmHg in females) and exhibit a
dramatic increase in SABP (up to 210 mmHg and more)
when restrained [6, 7]. The ISIAH rats also show a number
of other characteristic features of hypertensive state:
hypertrophy of the left ventricle, increase in the wall thick-
ness of the small arteries, and changes in the electrocardio-
graphic pattern [7]. ISIAH rats are also characterized by
increased kidney mass [8] and some alterations in kidney
histology indicative of increase in filtration barrier func-
tional load and of initial stages of glomerular [9] and
renomedullar sclerosis [10]. These features, the genetically
determined enhanced responsiveness to stressful stimula-
tion, and the predominant involvement of the neuroendo-
crine hypothalamic-pituitary-adrenocortical (HPA) and
sympathoadrenal systems during the disease development
let to consider the ISIAH rat strain as an advantageous
model of the human stress-sensitive hypertensive state [11].
Recently, the next-generation sequencing technologies be-
came very useful in providing deep insights into molecular
mechanisms underlying the complex diseases development
[12]. In the current work, the RNA sequencing (RNA-Seq)
technology was used for comparative analysis of renal
cortex transcriptome in hypertensive ISIAH and normoten-
sive control WAG (Wistar Albino Glaxo) rats. The goal of
the study was to identify the differentially expressed genes
(DEGs) related to hypertension and to detect the pathways
contributing to the differences in renal functions in hyper-
tensive ISIAH and normotensive WAG rats.
The study revealed multiple DEGs in renal cortex of
hypertensive ISIAH and normotensive WAG rats, in-
cluding 42 DEGs known as related to hypertension and
regulation of BP. These DEGs were associated with the di-
versity of biological processes and pathways which might
contribute to development of stress-sensitive hypertension.
Two of them (Ephx2 and Glp1r) were in the list of the top
40 genes showing the highest differences in expression in
ISIAH and WAG renal cortex.
Results
The analysis revealed 716 genes differentially expressed in
the renal cortex of hypertensive ISIAH and normotensive
WAG rats. About the half of DEGs (372 genes, i.e. 52,0 %)
were downregulated in ISIAH renal cortex. The expres-
sion of nine of these genes was detected in renal cortex of
WAG rats but not in ISIAH. Alternatively, only one gene
was expressed in ISIAH and silent in WAG renal cortex
(Table 1). No one of these genes expressed in renal cortex
of only one rat strain is known as related to hypertension
development. The list of the top 40 genes showing the
highest differences in expression in ISIAH and WAG
renal cortex contained two genes (Ephx2 and Glp1r) asso-
ciated with hypertension (Table 2).
Altogether, the study revealed 39 DEGs annotated in
RGD as related to hypertension (Table 3). Six of these
genes (Ace, Cyp2j4, Gja1, Mmp9, Ppara, and Ren) were
described as genes associated with renal hypertension.
According to functional annotation in DAVID, three
additional DEGs (Guca2b, P2rx4, and Pcsk5) might be
associated with regulation of BP. These DEGs may be
considered as potential candidate genes related to blood
pressure complications in ISIAH rats. Most of these genes
were downregulated in hypertensive kidney. The majority
of the DEGs associated with hypertension were related to
insulin resistance and diabetic nephropathy and about half
of them were associated with the immune system diseases
(Table 3). Altogether, the study revealed 60 DEGs referred
in RGD as associated with renal diseases, including renal
fibrosis, renal insufficiency, glomerulonephritis, diabetic
nephropathy, and nephrosclerosis (Table 4).
Table 1 Genes expressed at detectable levels in renal cortex of only one of rat strains
Gene symbol Acc.# Value, FPKM Gene name q-value
WAG ISIAH
Cyp2c24 NM_001271354.1 10.30 0 Cytochrome P450, family 2, subfamily c, polypeptide 24 0.002
Hpse2 NM_001135762.1 1.34 0 Heparanase 2 0.002
LOC100362965 XM_002728491.2 5.57 0 SNRPN upstream reading frame protein-like 0.002
LOC102546948 XR_352663.1 7.28 0 Uncharacterized LOC102546948, transcript variant X2 0.002
LOC102547398 XR_358422.1 9.97 0 Uncharacterized LOC102547398 0.002
LOC102553584 XR_362425.1 1.87 0 Uncharacterized LOC102553584 0.002
RGD1309362 NM_001024884.1 2.45 0 Similar to interferon-inducible GTPase 0.002
Sfta2 NM_001166020.1 8.22 0 Surfactant associated 2 0.003
Slpil2 NM_001008872.1 2.25 0 Antileukoproteinase-like 2 0.029
Rpl38-ps1 XR_593941.1 0 2.45 Ribosomal protein L38, pseudogene 1 0.030
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Table 2 Top 40 genes with the greatest difference in expression between ISIAH and WAG renal cortices
Gene symbol Acc. # Gene name log2 fold change ISIAH/WAG
RGD1565131 XM_006248902.1 60S ribosomal protein L15-like 8.57
Fam111a NM_001109163.1 Family with sequence similarity 111, member A 5.35
Stk32c XM_006230485.1 Serine/threonine kinase 32C, transcript variant X1 4.91
Resp18 NM_019278.1 Regulated endocrine-specific protein 18 4.82
Ubd NM_053299.2 Ubiquitin D 4.55
Ephx2a XM_006252147.1 Epoxide hydrolase 2, cytoplasmic, transcript variant X1 4.48
Akr1b8 XM_006236251.1 Aldo-keto reductase family 1, member B8, transcript variant X1 4.45
Hpgd NM_024390.2 Hydroxyprostaglandin dehydrogenase 15 (NAD) 4.30
Ly6al XM_006241767.1 Lymphocyte antigen 6 complex, locus A-like, transcript variant X1 4.14
Spta1 NM_001011908.3 Spectrin, alpha, erythrocytic 1 (elliptocytosis 2) 4.07
Tcerg1l NM_001130077.1 Transcription elongation regulator 1-like 3.91
Glp1ra XR_362044.1 Glucagon-like peptide 1 receptor, transcript variant X1 3.79
LOC686967 XM_003749071.2 Similar to olfactory receptor 1442 3.72
LOC102551856 XR_353697.1 Uncharacterized LOC102551856, transcript variant X1 3.46
Mx2 XM_006248150.1 Myxovirus (influenza virus) resistance 2, transcript variant X1 3.40
Krt19 NM_199498.1 Keratin 19 3.37
Ppp2r2c NM_057116.1 Protein phosphatase 2, regulatory subunit B, gamma 3.27
G6b XM_006256069.1 G6b protein, transcript variant X1 3.09
LOC102555352 XR_350674.1 Uncharacterized LOC102555352, transcript variant X4 3.05
RGD1564278 XM_003749906.2 RNA-binding protein with serine-rich domain 1-like 3.02
Kcne1 XM_006248034.1 Potassium voltage-gated channel, Isk-related family, member 1, transcript variant X2 2.89
LOC102546968 XM_006256098.1 RT1 class I histocompatibility antigen, AA alpha chain-like 2.87
Grhl1 XM_234006.7 Grainyhead-like 1 (Drosophila) 2.85
Fat3 XM_006242552.1 FAT atypical cadherin 3, transcript variant X1 −2.86
Fabp4 NM_053365.1 Fatty acid binding protein 4, adipocyte −3.23
Rbp4 NM_013162.1 Retinol binding protein 4, plasma −3.29
LOC361914 NM_001017465.1 Similar to solute carrier family 7 (cationic amino acid transporter, y + system),
member 12
−3.32
Cyp24a1 XM_006235672.1 Cytochrome P450, family 24, subfamily a, polypeptide 1, transcript variant X1 −3.47
B3gat1 XM_006242733.1 Beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P), transcript variant X1 −3.47
LOC102552001 XR_350962.1 Uncharacterized LOC102552001, transcript variant X1 −3.60
Hhip NM_001191817.1 Hedgehog-interacting protein −3.64
Slc22a13 XM_006244092.1 Solute carrier family 22 (organic anion/urate transporter), member 13,
transcript variant X1
−3.69
LOC102546318 XR_361882.1 Uncharacterized LOC102546318 −3.97
LOC102548532 XR_360708.1 Uncharacterized LOC102548532 −4.00
LOC102553060 XR_362149.1 Uncharacterized LOC102553060, transcript variant X1 −4.10
LOC102550987 XR_360671.1 Uncharacterized LOC102550987 −4.11
LOC501110 NM_001024361.1 Similar to Glutathione S-transferase A1 (GTH1) (HA subunit 1) (GST-epsilon)
(GSTA1-1) (GST class-alpha)
−4.26
Pcdh9 NM_001191688.1 Protocadherin 9 −4.67
Pdilt NM_001013902.1 Protein disulfide isomerase-like, testis expressed −5.06
LOC100360791 XM_003748668.2 Tumor protein, translationally-controlled 1 −7.45
a-genes associated with hypertension
Fedoseeva et al. BMC Genetics 2016, 17(Suppl 1):12 Page 7 of 48
Table 3 Genes differentially expressed in ISIAH versus WAG renal cortex and annotated in databases as associated with hypertension
and blood pressure regulation
Gene symbol Acc. # Gene name log2 fold change ISIAH/WAG
Rat genome database
Aceabc NM_012544.1 Angiotensin I converting enzyme −1.18
Acsm3c XM_006230106.1 Acyl-CoA synthetase medium-chain family member 3, transcript variant X2 2.51
Adra1bb NM_016991.2 Adrenoceptor alpha 1B −1.24
Adra2a NM_012739.3 Adrenoceptor alpha 2A −1.01
Alas1 NM_024484.2 Aminolevulinate, delta-, synthase 1 0.47
Angpt1 XM_006241609.1 Angiopoietin 1, transcript variant X1 0.69
Apobabc NM_019287.2 Apolipoprotein B −2.52
Arg2ac NM_019168.1 Arginase 2 −0.58
Cdo1 XM_006254698.1 Cysteine dioxygenase type 1, transcript variant X1 −0.78
Cluac XM_006252094.1 Clusterin, transcript variant X1 −1.75
Comt NM_012531.2 Catechol-O-methyltransferase −0.82
Cst3abc NM_012837.1 Cystatin C −0.50
Cyp1a1c NM_012540.2 Cytochrome P450, family 1, subfamily a, polypeptide 1 −1.04
Cyp2j4a NM_023025.2 Cytochrome P450, family 2, subfamily j, polypeptide 4 −0.81
Cyp4a8 NM_031605.2 Cytochrome P450, family 4, subfamily a, polypeptide 8 −0.55
Ephx1c NM_012844.3 Epoxide hydrolase 1, microsomal (xenobiotic), transcript variant 2 0.59
Ephx2ab XM_006252147.1 Epoxide hydrolase 2, cytoplasmic, transcript variant X1 4.48
Gja1c XM_006256503.1 Gap junction protein, alpha 1, transcript variant X2 0.54
Glp1r XR_362044.1 Glucagon-like peptide 1 receptor, transcript variant X1 3.79
Hsd11b2c NM_017081.2 Hydroxysteroid 11-beta dehydrogenase 2 0.60
Itgavb XM_006234437.1 Integrin, alpha V −0.62
Klk1c12ab NM_001005382.1 Kallikrein 1-related peptidase C12 −1.86
Klkb1ac XM_006253121.1 Kallikrein B, plasma 1, transcript variant X1 2.22
Mifbc NM_031051.1 Macrophage migration inhibitory factor (glycosylation-inhibiting factor) 0.50
Mmp9ac XM_006235619.1 Matrix metallopeptidase 9, transcript variant X1 −2.49
Mthfrac XM_006239414.1 Methylenetetrahydrofolate reductase (NAD(P)H), transcript variant X2 0.49
Pparabc XM_006242154.1 Peroxisome proliferator activated receptor alpha, transcript variant X4 −0.56
Ptgdsab NM_013015.2 Prostaglandin D2 synthase (brain) −0.67
Ptk2bbc XM_006252145.1 Protein tyrosine kinase 2 beta, transcript variant X3 −0.51
Rena NM_012642.4 Renin −0.49
RT1-Bbc NM_001004084.2 RT1 class II, locus Bb −0.78
Slc26a4 XM_006239978.1 Solute carrier family 26 (anion exchanger), member 4, transcript variant X3 0.46
Slc2a4b NM_012751.1 Solute carrier family 2 (facilitated glucose transporter), member 4 −0.77
Slc9a3r2 XM_006245893.1 Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
regulator 2, transcript variant X2
−0.48
Sncg NM_031688.1 Synuclein, gamma (breast cancer-specific protein 1) −1.25
Sts XM_006256960.1 Steroid sulfatase (microsomal), isozyme S, transcript variant X1 −0.70
Tf abc NM_001013110.1 Transferrin −1.50
Vwfbc NM_053889.1 Von Willebrand factor 0.77
Xdhac NM_017154.1 Santhine dehydrogenase −0.77
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Thirty one transcription factor genes were differentially
expressed in ISIAH and WAG renal cortex (Table 5). One
of these (Ppara) is known as associated with hypertension,
glomerulonephritis, insulin resistance, and immune system
diseases. Its expression was downregulated in ISIAH rats.
Several genes which might play a key role in hyperten-
sion development in ISIAH rats were chosen for technical
validation of the difference in their transcriptional activity
in ISIAH and WAG renal cortex by real-time PCR (Fig. 1).
The correlation coefficient between the results of two
methods was 0.99.
Gene Ontology (GO) terms for biological processes
found to be significantly enriched are represented in
Additional file 1. As it is marked in this file, the majority
of gene groups defined by GO terms contain DEGs
associated with hypertension. Several groups of DEGs
which might be important for the development of the
stress-sensitive hypertension are given in bold in the file.
The genes in these groups are listed in Additional file 2.
Among the most significantly enriched GO terms, there
are several (regulation of hormone levels, hormone meta-
bolic processes, response to hormone and to insulin
stimuli) which suggest the existence of the hormone
dependent interstrain differences in renal cortex function.
Multiple DEGs were related to the response to stress
and regulation of response to stress. The particular types
of stress were specified by several GO terms such as
response to oxidative stress, response to hypoxia, and
response to fluid shear stress. In these groups, the DEGs
associated with hypertension might have a special role in
stress-sensitive hypertension development in ISIAH rats.
The two most essential groups of DEGs related to
regulation of biological processes were associated with
regulation of blood pressure and blood circulation.
Several other processes which may have an important
role in hypertension development were: nitrogen com-
pound biosynthetic process, ion transport, regulation of
calcium ion transport, homeostatic process (including
ion homeostasis and particularly calcium ion homeosta-
sis), and tissue remodeling.
The functional annotation revealed multiple DEGs
associated with the immune system process and with
regulation of immune response. KEGG analysis also
marked out several pathways significantly enriched with
DEGs related to immune system function (Table 6). The
other significantly enriched metabolic pathways were re-
lated to steroid hormone biosynthesis, tryptophan, gluta-
thione, nitrogen, and drug metabolism. The DEGs in the
identified KEGG pathways are listed in Additional file 3.
Discussion
It was well established that kidney is one of the target
organs in hypertension development [13]. In the current
study, RNA-Seq approach was performed to identify
genes with altered transcriptional activity in the renal
cortex of hypertensive ISIAH as compared to normoten-
sive WAG rats and to reveal those, which might be re-
sponsible for hypertension development in ISIAH rats.
Multiple DEGs associated with hypertension and renal
diseases were found, and the functional annotation of
DEGs helped to define the main biological processes and
pathways which might contribute to stress-sensitive
hypertension in ISIAH rats.
GO annotation results pointed out that the hormonal
regulation might have strong influences on renal function.
So, the group of 16 DEGs participating in the regulation
of hormone level might play an important role in
orchestration of the changes in physiological and metabolic
processes in ISIAH kidney (Additional file 2). Several of
them (Ace, Comt, Cyp1a1, Glp1r, Hsd11b2, and Ren) are
widely known as associated with hypertension development.
The angiotensin I-converting enzyme and renin (Ace
and Ren) are the key components of the renin-angiotensin
system (RAS). Their low expression found in the current
experiment is in a good agreement with the previous study
when real-time PCR showed the decreased mRNA level of
these genes in kidney cortex of 4-month old ISIAH males
[14]. Low-renin hypertension usually implies increased
retention of Na(+) [15]. As the statistically significant
plasma sodium increase was found in ISIAH rats as
compared to WAG [16], the low-renin hypertension in
ISIAH rats may arise due to the suppression of the RAS
by the sodium retention and elevated blood pressure.
Comt encodes the enzyme catechol-O-methyltransferase
metabolizing catecholamines. The inhibition of COMT in-
duces dopamine-dependent natriuresis [17]. The catechol-
O-methyltransferase-gene-disrupted mice were resistant to
salt-induced hypertension [18]. So, the decreased expres-
sion of Comt in the renal cortex of ISIAH rats may lead to
increase in renal dopaminergic effects and sodium
Table 3 Genes differentially expressed in ISIAH versus WAG renal cortex and annotated in databases as associated with hypertension
and blood pressure regulation (Continued)
David (regulation of blood pressure)
Guca2b NM_022284.2 Guanylate cyclase activator 2B 2.04
P2rx4 NM_031594.1 Purinergic receptor P2X, ligand-gated ion channel 4 −1.65
Pcsk5 XM_006231145.1 Proprotein convertase subtilisin/kexin type 5, transcript variant X2 0.53
Genes associated with: a-diabetic nephropathy; b-insulin resistance; c-immune system diseases
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Table 4 Genes differentially expressed in ISIAH versus WAG renal cortex and annotated in rat genome database as associated with
kidney diseases
Gene symbol Acc. # Gene name log2 fold change ISIAH/WAG
Abcb1ab NM_133401.1 ATP-binding cassette, sub-family B (MDR/TAP), member 1A −0.82
Abcc2b NM_012833.1 ATP-binding cassette, subfamily C (CFTR/MRP), member 2 −0.47
Aceabcd NM_012544.1 Angiotensin I converting enzyme −1.18
Acsm3c XM_006230106.1 Acyl-CoA synthetase medium-chain family member 3, transcript variant X2 2.51
Aif1c NM_017196.3 Allograft inflammatory factor 1 0.59
Angpt1 XM_006241609.1 Angiopoietin 1, transcript variant X1 0.69
Apobd NM_019287.2 Apolipoprotein B −2.52
Apoc2b XM_006228403.1 Apolipoprotein C-II, transcript variant X1 −1.20
Apohd NM_001009626.1 Apolipoprotein H (beta-2-glycoprotein I) −2.73
Arg2bd NM_019168.1 Arginase 2 −0.58
Atp6v1b1 XM_006236748.1 ATPase, H transporting, lysosomal V1 subunit B1, transcript variant X1 0.57
Bak1 NM_053812.1 BCL2-antagonist/killer 1 0.54
Bsnd NM_138979.2 Bartter syndrome, infantile, with sensorineural deafness (Barttin) 0.45
C1qac NM_001008515.1 Complement component 1, q subcomponent, A chain 0.59
Cfbabc NM_212466.3 Complement factor B −1.09
Cluabcd XM_006252094.1 Clusterin, transcript variant X1 −1.75
Cndp1cd NM_001007687.1 Carnosine dipeptidase 1 (metallopeptidase M20 family) −1.01
Col3a1ab NM_032085.1 Collagen, type III, alpha 1 −0.60
Comt NM_012531.2 Catechol-O-methyltransferase −0.82
Cst3d NM_012837.1 Cystatin C −0.50
Cyp1a1b NM_012540.2 Cytochrome P450, family 1, subfamily a, polypeptide 1 −1.04
Cyp2j4ad NM_023025.2 Cytochrome P450, family 2, subfamily j, polypeptide 4 −0.81
Cyp4a8 NM_031605.2 Cytochrome P450, family 4, subfamily a, polypeptide 8 −0.55
Ephx2bd XM_006252147.1 Epoxide hydrolase 2, cytoplasmic, transcript variant X1 4.48
Fgab NM_001008724.1 Fibrinogen alpha chain, transcript variant 1 1.00
Fhit NM_021774.1 Fragile histidine triad 0.80
Fmodd XM_006249885.1 Fibromodulin, transcript variant X1 −0.94
Gatmb NM_031031.2 Glycine amidinotransferase (L-arginine:glycine amidinotransferase) 0.74
Gfpt2d NM_001002819.2 Glutamine-fructose-6-phosphate transaminase 2 1.75
Gja1 XM_006256503.1 Gap junction protein, alpha 1, transcript variant X2 0.54
Gtpbp4b XM_006254146.1 GTP binding protein 4 1.77
Hao1 XM_006235096.1 Hydroxyacid oxidase (glycolate oxidase) 1, transcript variant X1 −1.68
Igfbp1d NM_013144.1 Insulin-like growth factor binding protein 1 1.09
Itgal XM_006230269.1 Integrin, alpha L, transcript variant X1 0.71
Kit XM_006250909.1 v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, transcript variant
X1
0.62
Klk1c12d NM_001005382.1 Kallikrein 1-related peptidase C12 −1.86
Klkb1cd XM_006253121.1 Kallikrein B, plasma 1, transcript variant X1 2.22
Lgals1 NM_019904.1 Lectin, galactoside-binding, soluble, 1 0.91
Mifc NM_031051.1 Macrophage migration inhibitory factor (glycosylation-inhibiting factor) 0.50
Mmec NM_012608.2 Membrane metallo-endopeptidase 0.55
Mmp9acd XM_006235619.1 Matrix metallopeptidase 9, transcript variant X1 −2.49
Mthfrbcde XM_006239414.1 Methylenetetrahydrofolate reductase (NAD(P)H), transcript variant X2 0.49
Muc20bc XM_006248449.1 Mucin 20, cell surface associated, transcript variant X1 0.63
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excretion, and may be considered as an adaptive mech-
anism. Earlier, the significantly decreased transcription
of Comt was also detected in kidney of 6-month old
ISIAH rats [19].
Cyp1a1 knockout mice are hypertensive. Cyp1a1
metabolizes omega-3 polyunsaturated fatty acids to
vasodilators and the loss of these vasodilators may
lead to increases in BP [20]. So, the decreased level
of Cyp1a1 transcription in ISIAH renal cortex sug-
gests its contribution to hypertension development in
these rats.
The enzyme encoded by 11β-hydroxysteroid de-
hydrogenase (Hsd11b2) oxidizes glucocorticoids to the
inactive metabolite cortisone. In aldosterone target
tissues, 11βHSD2 is coexpressed with mineralocortic-
oid receptors and protects the receptor from activa-
tion by glucocorticoids. It was found that decreased
HSD11B2 activity is related to hypertension [21] and
Hsd11b2 null mice are also hypertensive [22]. So, the
increased Hsd11b2 transcription in ISIAH renal cortex
may lead to decreased glucocorticoid action and be pro-
tective against excessive elevation of blood pressure.
GLP-1 receptor (Glp1r gene) was shown to be expressed
in glomerular capillary and vascular walls in the mouse
kidney. Its signaling plays a crucial role in protection
against increased renal oxidative stress [23]. So, Glp1r
upregulation in renal cortex of ISIAH rats may be
adaptive against the oxidative stress.
Several DEGs participating in the regulation of hor-
mone level are related to retinol metabolism (Cyp26b1,
Rbp4, and Retsat) and intracellular transport (Rbp1).
Retinoids (vitamin A and its analogs) are highly potent
regulators of cell differentiation, cell proliferation, and
apoptosis. Retinoids and/or retinoid-related proteins play
important role in the development of metabolic diseases,
primarily obesity, diabetes, and dyslipidemia [24]. Earlier,
several signs of metabolic syndrome, such as dislipidemia,
increased glucose content, and increased body weight
were described in ISIAH rats [25]. The elevated RBP4 was
reported in chronic kidney disease [26] and may contrib-
ute to insulin resistance in spontaneously hypertensive
rats [27]. Based on that, we suggest that the upregulation
of Rbp4 may be related to development of metabolic
syndrome in ISIAH rats, too.
RetSat saturates all-trans-retinol to all-trans-13,14-
dihydroretinol which is transiently oxidized to all-trans-
13,14-dihydroretinoic acid before being oxidized further
by Cyp26 enzymes [28]. Cyp26b1 catalyzes the inactiva-
tion of retinoic acid (RA) to hydroxylated forms and
helps to maintain tissue RA concentrations within
appropriate bounds [29]. The particular role of elevated
transcription of Retsat and Cyp26b1 in ISIAH kidney
function remains to be determined.
According to the functional annotation, four genes
responsible for regulation of hormone level (Ace, Glp1r,
Hsd11b2 and Ren) are also associated with the regulation
Table 4 Genes differentially expressed in ISIAH versus WAG renal cortex and annotated in rat genome database as associated with
kidney diseases (Continued)
Pla2g7abc XM_006244606.1 Phospholipase A2, group VII (platelet-activating factor acetylhydrolase,
plasma), transcript variant X1
0.71
Pparac XM_006242154.1 Peroxisome proliferator activated receptor alpha, transcript variant X4 −0.56
Ptgdsde NM_013015.2 Prostaglandin D2 synthase (brain) −0.67
Ptk2bc XM_006252145.1 Protein tyrosine kinase 2 beta, transcript variant X3 −0.51
Renbd NM_012642.4 Renin −0.49
Rhcgb NM_183053.1 Rh family, C glycoprotein 0.66
RT1-Bba NM_001004084.2 RT1 class II, locus Bb −0.78
Serpinf1d NM_177927.2 Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium
derived factor), member 1
−1.34
Slc17a2 NM_001107353.1 Solute carrier family 17, member 2 0.52
Slc19a3b NM_001108228.1 Solute carrier family 19 (thiamine transporter), member 3 0.66
Slc4a1 XM_006247255.1 Solute carrier family 4 (anion exchanger), member 1, transcript variant X1 0.86
Tfcd NM_001013110.1 Transferrin −1.50
Tgfbid NM_053802.1 Transforming growth factor, beta induced −0.93
Ttc21b NM_001191737.1 Tetratricopeptide repeat domain 21B −0.48
Vwfabc NM_053889.1 Von Willebrand factor 0.77
Wfs1 NM_031823.1 Wolfram syndrome 1 (wolframin) 0.50
Xdhabd NM_017154.1 Xanthine dehydrogenase −0.77
Genes associated with: a-renal fibrosis; b-renal insufficiency; c-glomerulonephritis, d-diabetic nephropathies; e-nephrosclerosis
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of BP. Two other genes in the group ‘regulation of BP’
(Ephx2, and Guca2b) were earlier described as common
genes related to regulation of BP in several rat models of
programmed hypertension [30]. In ISIAH renal cortex
these genes were upregulated. Ephx2 encodes the soluble
epoxide hydrolase (sEH) which metabolizes the epoxyei-
cosatrienoic acids (EETs) having antihypertensive prop-
erties. EETs also possess anti-inflammatory actions that
could protect the kidney vasculature from injury during
renal and cardiovascular diseases [31, 32]. sEH is consid-
ered as a main effector of angiotensin II-induced [31]
and salt-sensitive hypertension [33]. Besides, it was
considered as one of the gatekeeper genes contributing to
programmed hypertension [30]. The uroguanylin (Guca2b
encoded protein) deficiency results in impaired ability to
excrete an enteral load of NaCl, primarily due to an
inappropriate increase in renal Na + reabsorption, and in
increased mean arterial pressure in uroguanylin knockout
animals [34]. Based on this information, we may suggest
that upregulation of Ephx2 exerts the pressor effect and
Guca2b exerts an opposite effect on systemic BP and renal
function in ISIAH rats.
Three other DEGs related to regulation of BP (Adra1b,
P2rx4, and Ppara) were downregulated in ISIAH renal
cortex. The alpha1B-adrenoceptors (Adra1b) are involved
in blood vessel remodeling [35] and mediate the vasocon-
strictor actions of the renal sympathetic nerves in rats with
renal failure [36, 37]. PPARα is a nuclear transcription
Table 5 List of genes encoding transcription factors differentially expressed in ISIAH versus WAG renal cortex
Gene symbol Acc. # Gene name log2 fold change ISIAH/WAG
Bcl6 NM_001107084.1 B-cell CLL/lymphoma 6 −2.47
Btbd11 XM_006241173.1 BTB (POZ) domain containing 11 −0.98
Etv1 XM_006240048.1 Ets variant 1, transcript variant X2 −0.85
Etv5 XM_006248542.1 Ets variant 5, transcript variant X1 −0.84
Foxi1 NM_001105776.1 Forkhead box I1 0.48
Grhl1 XM_234006.7 Grainyhead-like 1 (Drosophila) 2.85
Hdac9 XM_006240037.1 Histone deacetylase 9, transcript variant X14 −0.89
Hes6 XM_006245407.1 Hes family bHLH transcription factor 6, transcript variant X1 −0.72
Hr XM_006252284.1 Hair growth associated, transcript variant X2 1.24
Irf4 XM_006253900.1 Interferon regulatory factor 4, transcript variant X2 −1.51
Irf7 NM_001033691.1 Interferon regulatory factor 7 1.52
Ivns1abp XM_006249989.1 Influenza virus NS1A binding protein, transcript variant X2 −0.59
Klf12 NM_001007684.1 Kruppel-like factor 2 −0.69
Mybl1 XM_006237749.1 Myeloblastosis oncogene-like 1, transcript variant X1 −1.37
Nfkbil1 XM_006256046.1 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1,
transcript variant X1
0.94
Nkd2 NM_001107454.1 Naked cuticle homolog 2 (Drosophila) −0.84
Osr2 XM_006241542.1 Odd-skipped related transciption factor 2, transcript variant X1 1.03
P8 XM_006230201.1 Nuclear proten 1 −1.86
Pou2af1 NM_001109599.1 POU class 2 associating factor 1 2.60
Ppara XM_006242154.1 Peroxisome proliferator activated receptor alpha, transcript variant X4 −0.56
Ppargc1b NM_176075.2 Peroxisome proliferator-activated receptor gamma, coactivator 1 beta −0.62
Prox1 XM_006250454.1 Prospero homeobox 1, transcript variant X1 −0.74
Satb2 XM_006244931.1 SATB homeobox 2, transcript variant X1 −1.13
Sox9 XM_003750950.2 SRY (sex determining region Y)-box 9 −0.80
Spry4 XM_006254656.1 Sprouty homolog 4 (Drosophila), transcript variant X2 −0.70
Tcerg1l NM_001130077.1 Transcription elongation regulator 1-like 3.91
Tcf4 NM_053369.1 Transcription factor 4 −0.90
Zbtb16 XM_006243015.1 Zinc finger and BTB domain containing 16, transcript variant X1 −1.20
Zdhhc2 NM_145096.2 Zinc finger, DHHC-type containing 2 0.67
Zfp36 NM_133290.3 Zinc finger protein 36 −0.61
Zfp385b NM_001107736.1 Zinc finger protein 385B 0.67
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factor. It contributes to regulation of BP and vascular
reactivity in SHR [38]. PPARα deficiency appears to
aggravate the severity of diabetic nephropathy through an
increase in extracellular matrix formation, inflammation,
and circulating free fatty acid and triglyceride concentra-
tions [39]. Alternatively, the PPAR-alpha and -gamma
agonists attenuate diabetic kidney disease in the apolipo-
protein E knockout mice [40]. P2rx4(-/-) mice have higher
BP and excrete smaller amounts of NO products in their
urine than do wild-type mice. They have impaired flow-
dependent control of vascular tone and remodeling [41].
Besides, the lack of P2X4R expression leads to increased
renal fibrosis [42]. So, we may suggest that downregulation
of Adra1b may be adaptive and protect against the
excessive sympathoexcitation, and P2rx4, and Ppara defi-
ciency may contribute to development of kidney pathology
in ISIAH rats.
In the current study, we found multiple DEGs related
to response to different stimuli and to stress. This is well
consistent with the previous observation that HPA and
sympathoadrenal systems are activated in ISIAH rats
[11] and that the changes in kidney function of 6-month
old ISIAH rats are based on altered expression of many
genes working in stress-related mode [19]. The stress
response (or stress cascade) is considered as disruptions
in homeostasis which result in a series of neural and
endocrine adaptations. The stress cascade is responsible
for allowing the body to make the necessary physio-
logical and metabolic changes required to cope with the
demands of a homeostatic challenge [43]. In the current
study, the functional annotation helped to identify
multiple DEGs involved in homeostatic process. Several
DEGs in this group were associated with both hyperten-
sion and kidney diseases. That is in a good agreement
with the opinion that essential hypertension is one of
the “syndromes of impaired genetic homeostasis” [44]
and that homeostatic process might be impaired in
patients with chronic kidney disease [45].
Earlier, the comparative electron microscopic study of
glomerular apparatus in 6-month old ISIAH and Wistar
rats showed hypertrophy of renal corpuscles in hyperten-
sive kidney, accompanied by multiple structural changes
such as capillary narrowing or dilation, endothelial flatten-
ing, podocyte hypertrophy and flattening of their cytopodia,
thickening of basal lamina, mesangial volume expan-
sion and increase in the number of intercapillary
processes of mesangial cells [9]. Complex of these signs
suggested a disturbance of glomerular capillary blood
circulation and a functional podocyte stress, compen-
sating the microcirculatory disturbances. Changes in
basal membranes and mesangium were considered as
indicative of increase in filtration barrier functional
load, and of initial stages of glomerular sclerosis [9]. In
the current study, we used younger rats, nevertheless,
we found groups of DEGs associated with blood circula-
tion, renal hypertension, and with the development of
Fig. 1 Comparison of gene expression level measurements obtained by RNA-seq and qPCR
Table 6 Metabolic pathways significantly enriched with genes
differentially expressed in ISIAH and WAG renal cortices
Term Count P-value
Complement and coagulation cascades 9 0.003
Type I diabetes mellitus 8 0.005
Cell adhesion molecules (CAMs) 13 0.006
Drug metabolism 8 0.014
Steroid hormone biosynthesis 6 0.018
Tryptophan metabolism 6 0.018
Metabolism of xenobiotics by cytochrome P450 7 0.020
Glutathione metabolism 6 0.032
Antigen processing and presentation 8 0.037
Nitrogen metabolism 4 0.047
Fedoseeva et al. BMC Genetics 2016, 17(Suppl 1):12 Page 13 of 48
nephrosclerosis. Probably, the changes in their expression
may be potentially important for the appearance of
the microcirculatory and structural disturbances in
aging kidney.
The particular types of stress specified by GO terms
were associated with oxidative stress, hypoxia, and fluid
shear stress (Additional file 1). The oxidative stress is
considered to be the pathogenic outcome of oxidant
overproduction, which occurs as a result of imbalance
between prooxidants and antioxidants [46]. Several
genes in this group showed reduced transcription and
several were upregulated.
The protein encoded by Abcc2 mediates transport of
various molecules across extra- and intra-cellular mem-
branes, including the transport of prostaglandin E2 [47],
which affects multiple segments of the preglomerular
vascular tree in a different ways [48]. ABCC2 deficiency
may be associated with increased oxidative stress, lead-
ing to renal tubular cell damage [49].
Two other genes associated with response to oxidative
stress (Clu and Mmp9) are known as genes related to
hypertension and kidney diseases. Clusterin (Clu) upreg-
ulation attenuates renal fibrosis in obstructive nephropa-
thy [50]. Alternatively, the loss of clusterin expression
worsens renal ischemia-reperfusion injury [51]. Over-
expression of MMP9 could alter glomerular basement
membrane components thereby causing podocyte struc-
tural changes [52]. MMP9 is also known to cleave podoca-
lyxin in podocytes, which is a charge barrier to prevent
microalbuminuria [53]. Loss of MMP9 reduces athero-
sclerotic burden [54] and, alternatively, the elevated urine
values of MMP-9 was recognized as a marker of athero-
sclerotic disease [55]. So, the decrease in Clu and Mmp9
expression may be protective in ISIAH renal cortex.
Another gene repressed in ISIAH renal cortex and
related to oxidative stress was Hao1. It encodes a peroxi-
somal enzyme that oxidizes glycolate to glyoxylate with
concomitant production of H2O2. Downregulation of
Hao1 expression during oxidative stress may provide a
mechanism to prevent excessive H2O2 formation [56].
Alpha B-crystallin (Cryab gene) is a ubiquitous stress
inducible molecular chaperone. CRYAB is promoting
angiogenesis and preventing apoptosis [57]. Expression of
cystatin C has protective effects against various oxidative
stresses that induce cell death [58]. Its decreased tran-
scription in ISIAH renal cortex may contribute to oxida-
tive damage and, probably, to hypertension development.
It is known that chronic hypertension can occur if
there is an abnormality of kidney function that shifts
pressure natriuresis so that sodium balance is main-
tained at elevated blood pressures [59]. Tubular sodium
reabsorption depends on the activity of ion transport
systems, which are modulated by neural, endocrine,
paracrine, and physical factors [60]. In our study, the
functional annotation revealed 32 DEGs related to ion
transport. The changes in their transcriptional activity
suggest that different mechanisms of osmoregulation may
contribute to function of hypertensive kidney. These
results are in a good agreement with the statement that
ion transport is one of the major processes that are vital
for functions of kidney and organism as a whole.
KEGG analysis showed an overrepresentation of DEGs
involved in several metabolic pathways (Table 6 and
Additional file 3). The most significantly enriched one
was pathway associated with complement and coagula-
tion cascades. Inflammation and coagulation play pivotal
roles in the pathogenesis of vascular diseases. Increasing
evidence points to an extensive cross-talk between these
two systems, whereby inflammation leads not only to ac-
tivation of coagulation, but coagulation also considerably
affects inflammatory activity [61].
One of the DEGs related to this pathway (Fga) is
involved in platelet aggregation and has been recognized
as biomarker for acute kidney injury [62]. Its upregulation
may contribute to enhanced coagulation and exert negative
effect on ISIAH kidney function. The other upregulated
gene related to complement and coagulation cascades
(Serpinc1) contributes to negative regulation of inflamma-
tory response and to fibrinolysis. Serpinc1 deficiency is
significantly associated with a tendency toward thrombosis
formation in the kidney [63]. So, its upregulation may exert
a protective effect on ISIAH kidney function.
Two another upregulated DEGs (Klkb1 and Vwf ) in
the complement and coagulation cascades are known as
associated with both hypertension and kidney diseases.
Plasma prekallikrein (Klkb1 gene) was considered as a
risk marker for hypertension and nephropathy in type 1
diabetes. Its level was elevated in association with
increased blood pressure, and positively correlated with
urinary albumin excretion rate [64]. As for Vwf gene, it
was demonstrated that immobilization stress exposure
was followed by a rise in von Willebrand factor concentra-
tions, adrenocorticotropic hormone and corticosterone
release in saline pretreated rats [65]. The enhanced Vwf
gene transcription in ISIAH renal cortex suggests that it
may be one of the genes working in stress-related mode in
renal cortex of ISIAH rats.
Several pathways found in the current study were
closely related to the immune system function. It is long
known that the immune system changes play a role in
hypertension and an extensive bidirectional interactions
between the sympathetic nervous system and the im-
mune system exist [66, 67]. Recent studies have shown
that both innate and adaptive immunity contribute to
hypertension [68]. Major histocompatibility complex
(MHC) class I molecules are ligands for the killer-cell
immunoglobulin-like receptors, which are expressed by
natural killer (NK) cells and T cells. The interactions
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between these molecules contribute to both innate and
adaptive immunity [69]. MHC class-II molecules are key
participants in immune activation events in autoimmunity
[70]. It was shown that mice lacking adaptive immune
cells, including recombinase-activating gene-deficient
mice and rats and mice with severe combined immuno-
deficiency have blunted hypertension to stimuli such as
ANG II, high salt, and norepinephrine [71]. The current
work helped to reveal several genes related to MHC class
I and MHC class II which might be useful for further
studies of immune system changes during hypertension
development in ISIAH rats.
Several other pathways were significantly enriched
with DEGs related to steroid hormone biosynthesis,
tryptophan, glutathione, nitrogen, and drug metabolism.
The most DEGs associated with hypertension in these
pathways were related to steroid hormone biosynthesis
and were discussed above. The other pathways (glutathi-
one, nitrogen, and drug metabolism) didn’t contain the
DEGs directly associated with hypertension, however,
these also might play important role in pathology devel-
opment in ISIAH rats. This may be true, at least for the
glutathione metabolism. It is known that glutathione is
an important intracellular antioxidant that protects
against a variety of different oxidant species. Induction
of oxidative stress by glutathione depletion causes severe
hypertension in normal rats [72]. In our study, we found
several DEGs involved in glutathione metabolism. GPx2
is a key enzyme in the antioxidant system of the cells
[73]. The glutathione S-transferases provide cellular
protection against the toxic effects of a number of envir-
onmental toxicants and products of oxidative stress by
conjugation with glutathione [74]. So, we may suggest
that downregulation of glutathione S-transferases may
weaken oxidative defense and mediate the pathological
processes in ISIAH kidney and the upregulation of Gpx2
seems to play a protective role.
Conclusion
The results of the study revealed multiple genes differen-
tially expressed in renal cortex of hypertensive ISIAH
and normotensive WAG rats, including 42 genes associ-
ated with hypertension and regulation of BP. Their func-
tional annotation showed that many different processes
might be brought into play. Two DEGs associated with
hypertension (Ephx2 and Glp1r) were in the list of the
top 40 genes showing the highest differences in expres-
sion in ISIAH and WAG renal cortex. These DEGs may
be considered as potential candidates for further studies to
better understand the mechanisms of the hypertension
development in the ISIAH rats. The results of the discus-
sion suggested that the interstrain differences in ISIAH
and WAG renal function may probably arise from the
imbalance in processes leading to the development of
pathology from one side and the processes trying to restore
the homeostasis from the other side. As the number of hyper-
tensive and the other potentially relevant genes was consider-
able, we were not able to discuss all of them in details.
Our findings provide a basis for identification of
potential biomarkers of stress-sensitive hypertension and
further investigation of the signaling mechanisms that




The work was carried out on hypertensive ISIAH and
normotensive WAG rats bred in the Center for Genetic
Resources of Laboratory Animals at the Institute of
Cytology and Genetics, Siberian Branch of the Russian
Academy of Sciences, (Novosibirsk, Russia, RFME-
FI61914X0005 and RFMEFI61914X0010). All rats were
maintained in the standard conditions with free access
to food and water. The systolic arterial blood pressure
(BP) was measured indirectly by the tail-cuff method.
The BP level was determined under short-term ether
anesthesia to exclude the effect of psychological stress
induced by the measuring procedure. In RNA-seq
experiments the 3-month old ISIAH (n = 3), and
WAG (n = 3) males were used. Their systolic arterial
BP was 171.7. ± .1.22 mmHg in ISIAH and 116.33 ±
1.86 mmHg in WAG males. The kidney of the decapitated
rats was immediately removed and sectioned to get the
samples of renal cortex which were stored in RNA Later
(Qiagen, Chatsworth, CA) at −70 °C until use. All animal
experiments were approved by the Institute’s Animal Care
and Use Committee.
RNA-seq analysis
The collected samples of renal cortex were sent to JSC
Genoanalytica (Moscow, Russia), where mRNA was
extracted using Dynabeads mRNA Purification Kit
(Ambion, USA). cDNA libraries were constructed using
NEBNext mRNA Library Prep Reagent Set for Illumina
(NEB, USA) following the manufacturer’s protocol and
were subjected to Illumina single-end sequencing. Three
renal cortex samples from ISIAH and three renal cortex
samples from WAG rats were run as experimental
replicates. The resulting fastq-formatted sequencing data
were mapped to the RGSC Rnor_5.0\rn5 reference gen-
ome using Tophat2 aligner [75] and NCBI RefSeq gene
annotation. Quality assessment of the mapped data was
performed using the module ‘CollectRnaSeqMetrics’ from
Picard tools suite (http://broadinstitute.github.io/picard/).
The summary statistics for each sequenced library is given
in Additional file 4. The Cufflinks/Cuffdiff programs were
then used to estimate gene expression levels in FPKM
(fragments per kilobase of transcript per million
Fedoseeva et al. BMC Genetics 2016, 17(Suppl 1):12 Page 15 of 48
mapped reads), and to perform differential expression
analysis [76]. Genes were considered to be differen-
tially expressed at q value < 0,05.
Functional annotation
The functional analysis of DEGs was performed using
DAVID (The Database for Annotation, Visualization and
Integrated Discovery) tool (http://david.abcc.ncifcrf.gov/)
[77, 78]. The Gene Ontology option was utilized to
determine the significantly (p < 0.05) enriched biological
processes and groups of genes possibly contributing to
hypertensive phenotype in ISIAH rats. The Kyoto
Encyclopedia of Genes and Genomes Pathway Database
(KEGG, http://www.genome.jp/kegg/) was used to
identify pathways that were most significant to the data
set. The genes related to hypertension and renal diseases
were detected according to the DEGs annotation in
Rat Genome Database (RGD, http://rgd.mcw.edu/).
The detection of transcription factors among DEGs
was performed using gene annotations from GenBank
(http://www.ncbi.nlm.nih.gov/gene/), an atlas of combina-
torial transcriptional regulation in mouse and man [79] and
Panther classification system (http://www.pantherdb.org/).
Quantitative real-time PCR (qPCR)
The relative amount of target mRNA was measured by
qPCR. Samples of renal cotrtex were analyzed in 3-
month old ISIAH and WAG rats. Each group contained
five rats. Total RNA was extracted using the TRI reagent
(Molecular research center, USA). Remaining traces of
genomic DNA were removed from the RNA samples
using DNase I (Promega, USA) treatment, according to
the manufacturer’s instructions.
Reverse transcription was performed in 50 μl of RT
buffer containing 3 μg of total RNA, 0.25 nmol of random
nonanucleotide primers (Biosan, Russia), 0.4 mM dNTP,
and 40 units of MoMLV (Vektor-Best, Russia). The cDNA
was synthesized at 37 °C (1 h), 42 °C (30 min), and 50 °C
(10 min). The enzyme was inactivated by heating the
mixture at 75 °C for 5 min.
qPCR was performed in a final volume of 20 μl. The
reaction volume contained master mix with SYBR
Green, forward and reverse primers (0,15 mM each), 1
unit of HotStart Taq polymerase (Vektor-Best, Russia),
and the cDNA template. The housekeeping gene Rpl30
encoding ribosomal protein L30 was used as a reference
gene. Primer’s sequences, their annealing temperatures,
and the temperatures of fluorescence signal acquisition
are given in Additional file 5.
qPCR was carried out in an iCycler iQ4 Real-Time
PCR Detection System (Bio-Rad Laboratories, USA) with
an initial denaturation of 1 min at 94 °C followed by
40 cycles of 15 s at 94 °C, 20 s at primer’s annealing
temperatures (see Additional file 5), 20 s at 72 °C,
fluorescence signal acquisition for 10 s, and then gener-
ation of melting curve from 65 to 94 °C. The standard-
curve quantitation method was applied [80]: the relative
amount of the tested cDNA was determined using cali-
bration curves derived from the dilutions of the standard
cDNA. Standard cDNA solution for plotting calibration
curves was obtained by mixing aliquots from each of the
synthesized cDNA samples. In each experiment, cDNA
samples with primers for the target gene (four replicates
per cDNA sample), the same samples with primers for the
reference gene (four replicates), and the standard cDNA
dilutions (1 : 1, 1 : 4, 1 : 16, and 1 : 64) with the primers
for the target gene (two replicates), and with the primers
for the reference gene (two replicates) were placed on the
same plate. The value for the target gene was further
normalized against the qPCR level of the reference gene.
Statistical calculations for qPCR data were performed
with the software package Statistica v.6.0 (Statsoft, USA)
using nonparametric statistics, Mann-Whitney U-test.
Differences were considered statistically significant when
P was less than 0.05. The data were presented as means
and their standard errors (M ± S.E.M.).
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